Circulating Prostate Cancer Progenitor Cell Assay Development

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$747,553.00
Award Year:
2011
Program:
STTR
Phase:
Phase II
Contract:
W81XWH-08-C-0099
Agency Tracking Number:
A2-4144
Solicitation Year:
2008
Solicitation Topic Code:
A08-T041
Solicitation Number:
2008.A
Small Business Information
AndroBioSys, Inc.
73 High Street, Buffalo, NY, 14203-1149
Hubzone Owned:
Y
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
193493157
Principal Investigator:
Michael Zwick
CEO
(716) 860-7920
mzwick@androbiosys.com
Business Contact:
Michael Zwick
CEO
(716) 860-7920
mzwick@androbiosys.com
Research Institution:
Roswell Park Cancer Institute
John T Blandino
Elm and Carlton Streets
Buffalo, NY, 14263-
(716) 845-2312
Domestic nonprofit research organization
Abstract
The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cells. We propose to utilize the information from the Phase I award and subsequent research to develop assay reagents that would be used to develop a blood-based assay specific for circulating prostate cancer stem cells. This assay should prove to be an informative prognostic tool for predicting aggressiveness and metastatic potential of prostate cancer.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government